Heterozygous methylene tetrahydrofolate reductase mutation with mild hyperhomocysteinemia associated with deep vein thrombosis

Clinical and Laboratory Haematology

Volumn 26, Issue 2, 2004, Pages 143-146

  Pathare, A ^a,b   Alkindi, S ^a   Albalushi, T ^a   Bayoumi, R ^a   Dennison, D ^a   Muralitharan, S ^a  

^a SULTAN QABOOS UNIVERSITY HOSPITAL   (Oman)

^b SULTAN QABOOS UNIVERSITY   (Oman)

Author keywords

Hyperhomocysteinemia; Methylene tetrahydrofolate reductase; Thrombophilia

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); CYANOCOBALAMIN; FOLIC ACID; GENOMIC DNA; HEPARIN; WARFARIN;

ADULT; ANTICOAGULANT THERAPY; ARTICLE; CASE REPORT; DEEP VEIN THROMBOSIS; DISEASE MARKER; DOPPLER ECHOCARDIOGRAPHY; ERYTHROCYTE LEVEL; GENE MUTATION; HETEROZYGOTE; HUMAN; HYPERHOMOCYSTEINEMIA; HYPOCHONDRIASIS; ILIAC VEIN; INFERIOR CAVA VEIN; INTERNATIONAL STANDARD UNIT; MALE; POLYMERASE CHAIN REACTION; POPLITEAL VEIN; PRIORITY JOURNAL; RECURRENT DISEASE; THROMBOPHILIA; ULTRASOUND; VITAMIN BLOOD LEVEL;

ADULT; ARTERIAL OCCLUSIVE DISEASES; ERYTHROCYTES; FOLIC ACID; HETEROZYGOTE; HUMANS; HYPERHOMOCYSTEINEMIA; ILIAC VEIN; MALE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MUTATION; POPLITEAL VEIN; VENA CAVA, INFERIOR; VENOUS THROMBOSIS; VITAMIN B 12;

EID: 1942441765     PISSN: 01419854     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2257.2004.00585.x     Document Type: Article

References (14)

1. Amundsen T., Ueland P.M. & Waage A. (1995) Plasma homocysteine levels in patients with deep venous thrombosis. Arteriosclerosis. Thrombosis, and Vascular Biology 15, 1321-1323.
2. Butthep P., Bunyaratvej A., Funahara Y., Kitaguchi H., Fucharoen S., Sato S. & Bhamarapravati N. (1997) Possible evidence of endothelial cell activation and disturbance in thalassemia: an in vitro study. Southeast Asian Journal of Tropical Medicine and Public Health 28(Suppl. 3), 141-148A.
3. Cattaneo M. (1999) Hyperhomocysteinemia, atherosclerosis and thrombosis. Thrombosis and Haemostasis 81, 165-176.
4. Den Heijer M., Koster T., Blom H.J., Bos G.M.J., Breit E., Reitsma P.H., Vandenbroucke J.P. & Rosendaal F.R. (1996) Hyperhomocysteinemia as a risk factor for deep venous thrombosis. New England Journal of Medicine 334, 759-762.
5. Falcon C.R., Cattaneo M., Panzeri D., Martinelli I. & Mannucci P.M. (1994) High prevalence of hyperhomocysteinemia in patients with juvenile venous thrombosis. Arteriosclerosis, Thrombosis, and Vascular Biology 14, 1080-1083.
6. Fermo L., D'Angelo S.V., Paroni R., Mazzola G., Calori G. & D'Angelo A. (1995) Prevalence of moderate hyperhomocysteinemia in patients with early-onset venous and arterial occlusive disease. Annals of Internal Medicine 123, 747-753.
7. Gemmati D., Previati M., Serino M.L., Moratelli S., Guerra S., Capitani S., Forini E., Ballerini G. & Scapoli G.L. (1999) Low folate levels and thermolabile methylenetetrahydrofolate reductase as primary determinant of mild hyperhomocysteinemia in normal and thromboembolic subjects. Arteriosclerosis, Thrombosis, and Vascular Biology 19, 1761-1767.
8. Jacques P.F., Bostom A.G., William R.R., Ellison R.C., Eckfeldt J.H., Rosenberg I.H., Selhub J. & Rozen R. (1996) Relation between folate status a common mutation in methylene tertahydrofolate reductase and plasma homocysteine concentrations. Circulation 93, 7-9.
9. Malinow M.R., Nieto F.J., Kruger W.D., Duell P.B., Hess D.L., Gluckman R.A., Block P.C., Holzgang C.R., Anderson P.H., Seltzer D., Upson B. & Lin Q.R. (1997) The effects of folic acid supplementation on plasma homocysteine are modulated by multivitamin use and methyltetrahydrofolate reductase genotypes. Arteriosclerosis. Thrombosis, and Vascular Biology 17, 1157-1162.
10. Miner S.E., Evroski J. & Cole D.E. (1997) Clinical chemistry and molecular biology of homocysteine metabolism: an update. Clinical Biochemistry 30, 189-201.
11. Murin S., Marelich G.P., Arroliga A.C. & Matthay R.A. (1998) Hereditary thrombophilia and venous thromboembolism. American Journal of Respiratory and Critical Care Medicine 158, 1369-1373.
12. Romana M., Murlitharan S., Ramasawmy R., Nagel R.L. & Krishnamoorthy R. (2002) Thrombosis-associated gene variants in sickle cell anemia. Thrombosis and Haemostasia 87, 356-358.
13. van Teunenbroek A., Wijburg F.A., ten Cate J.W., van den Berg W. & Weening R.S. (1989) Thromboembolic complications in an asplenic HbE-beta-thalassaemia patient. Netherlands Journal of Medicine 35, 123-127.
14. Wijburg F.A., van den Berg W., van Teunenbroek A. & Weening R.S. (1988) Thrombo-embolic complications after splenectomy in HbE-beta-thalassaemia. European Journal of Pediatrics 147, 444-445.